Lixisenatide improves glycemic outcomes of Japanese patients with type 2 diabetes: a meta-analysis

BACKGROUND: The GetGoal-L-Asia and -S trials were multi-center trials conducted in 4 and 16 countries, respectively including Japan that evaluated the efficacy and safety of lixisenatide add-on treatment vs. placebo among patients with type 2 diabetes. The aims of this study were to determine the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Seino, Hiroaki, Onishi, Yukiko, Naito, Yusuke, Komatsu, Mitsuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888474/
https://www.ncbi.nlm.nih.gov/pubmed/27252787
http://dx.doi.org/10.1186/s13098-016-0151-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888474/
https://www.ncbi.nlm.nih.gov/pubmed/27252787
http://dx.doi.org/10.1186/s13098-016-0151-7

Ejemplares similares